Assets
Cash equivalents:
$ 1,251
Investments in securities:
$ 156,539,168
Dividends and interest receivable:
$ 644,482
Other assets:
$ 30,621
Total Assets = $ 157,215,522
Liabilities and Net Assets
Grants approved for future payment:
$ 7,980,603
Accounts payable and accrued expenses:
$ 153,674
Deferred excise taxes:
$ 283,040
Total liabilities:
$ 8,417,317
Net assets:
$ 148,798,205
Total Liabilities and Net Assets = $ 157,215,522
Statements of Activities
Gain (loss) from investments:
$ 10,428,128
Investment related and other expenses:
$ (861,155)
Net gain (loss) from investments:
$ 9,566,973
Grants approved:
$ 7,609,862
Grant support:
$ 1,030,385
Total grants approved / related expenses:
$ 8,640,247
Net Gain (Loss) for the period = $ 926,726